TEC: Evidence Based Therapeutics
Therapeutics Education Collaboration
Medication Mythbusters – Home of the Best Science (BS) Medicine Podcast

Episode 219: Shining a bright light on the Vitamin D evidence – Part III

In episode 219, Mike and James final get to the end of the Vitamin D trilogy by reviewing the data for fractures and falls, mortality and cancer. At the end they identify that the best thing one can do when it comes to Vitamin D is to stand in the sun in a speedo bathing suit and eat mackerel – however the authorities intervene before that actually happened.

Show
notes

1) Vitamin D and fractures

Cochrane 2009;2:CD000227

Ann Intern Med 2011;155:827-38

Arch Intern Med 2009;169:551-61

N Engl J Med 2012;367:40-9

2) Vitamin D and falls

Cochrane 2009;2:CD007146

Cochrane 2010;1:CD005465

J Am Geriatr Soc 2010;58:1299-1310

BMJ 2009;339:b3692

Can Geriatric J 2011;14:93-9

Ann Intern Med 2010;153:815-25

J Clin Endocrinol Metab 2011;96:2997-3006

3) Vitamin D and mortality

Cochrane 2011;7:CD007470

Arch Intern Med 2007;167:1730-7

J Clin Endocrinol Metab 2012;97:2670–81

J Clin Endocrinol Metab 2011;96:1931–42

4) Vitamin D and Cancer

Ann Intern Med. 2011;155:827-38

Am J Clin Nut 2007;85:1586-91

5) Diabetes

Age Ageing 2009;38:606-9

Eur J Nutr 2009;48:349–54

Diabet Med 2008;25:320-5

6) Vitamin D and sun

J Clin Endo Metab 2009;94:1092–3

N Engl J Med 2007;357:266-81

7) Harm

Am J Clin Nutr 2007;85:6-18

Episode 218: Shining a bright light on the Vitamin D evidence – Part II

In episode 218, Mike and James give you more and more Vitamin D love. We look at Vitamin D for MS, depression and upper respiratory tract infections and basically Vitamin D does nothing for these conditions – so go forth and share the love – which means not recommending Vitamin D for these conditions.

Show notes

1) The Calcium and Vitamin “Bible”

Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine 2011. 

http://www.ncbi.nlm.nih.gov/books/NBK56070

2) Vitamin D and MS

Neurology 2004;62:60-5

J Neurol Neurosurg Psychiatry 2012;83:565e571

Neurology 2011;77:1611-8

Neurology 2010;74:1852-9

kampmanMult Scler 2012;18:1144-51

Immunol Invest 2011;40:627-39

3) Vitamin D and depression

Brit J Psych 2013; 202:100–7

Nutrition Journal 2004;3:8

J Int Med 2008 264:599–609

PLoS ONE 2011;6: e25966

Brit J Psych 2011;198:357–64

Brit J Psych 2012;201:360–8

Am J Epidemiol 2012;176:1–13

Menopause 2012;19:697–703

J Clin Psychopharmacol 2013;33:378-85

4)Vitamin D and URTI

Epidemiol Infect;2009:137:1396–1404

The Journal of Infectious Diseases 2010; 202:809–14

Rees JR, et al.  Clin Infect Dis. 2013 Sep 6. Pub online

JAMA 2012;308:1333-9

Am J Clin Nutr 2010;91:1255–60

BMJ Open 2012;2:e001663

Age and Ageing 2007;36: 574–92

Trop Med Int Health 2010;15:1148-55

Lancet 2012;379:1419–27

Episode 217: Shining a bright light on the Vitamin D evidence

In episode 217, Mike and James level the playing field by talking about the evidence behind recommended Vitamin D levels. We then start to look at the evidence for the use of Vitamin D in a variety of conditions, starting off with rheumatoid arthritis. At the end we realize the recommendations are far stronger than the evidence – surprise, surprise.

Show notes

1) The Calcium and Vitamin “Bible”

Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine 2011. 

2) Variability in measurements

J Clin Endocrin Metab 2004;89:3152-7

Ost Int 1999;9:394-7

3) Vitamin D levels and outcomes

Am J Clin Nutr 2006;84:18–28

BMJ 2009;339:b3692

Arch Intern Med 2009;169:551-61

4) Change in level with 800 IU

Scand J Clin Lab Invest 2006;66:227–38

5) Vitamin D and rheumatoid arthritis

Arthritis Rheum 2004;50:72-7

Ann Rheum Dis 2008;67:530–5

Autoimmun Rev 2012; 12:127–36

Semin Arthritis Rheum2011;40:512-31

Rheumatol Int 2012;32:3823–30

Rheumatol Int 2012;32:2129–33

Int J Rheum Dis 2011; 14:332–9

Scand J Rheumatology 1973;2:173-176

Episode 216: Questions that lead to questions and then more questions – Part IV

In episode 216, Mike and James finally get to the last of the listener questions. We discuss the numbers around the pneumococcal and influenza vaccines, metformin and contraindications, the timing of antihypertensives, and stuff for osteoporosis. Ironically we end with the question “does any of this mean anything in the grand scheme of things?” and we design a metaphorical RCT to answer that question.

Show notes

1) Metformin and harm

Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review

BMJ 2007;335:497

2) Metformin’s contraindications should be contraindicated

CMAJ 2005;173:502-4

2) MAPEC study

Chronobiol Int 2010;27:1629-51

3) Tools for Practice

Does calcium (Ca+) supplementation contribute to increased risk of myocardial infarction (MI) and other cardiovascular disease (CVD)?

4) CVD risk calculator

http://bestsciencemedicine.com/chd

See List of All Podcast Episodes

Search

11th Annual PEIP Conference October 21-22, 2022

Practical Evidence for Informed Practice Conference | October 21 & 22, 2022
Led by the team that brings you Tools for Practice, the Practical Evidence for
Informed Practice (PEIP) Conference brings together clinical leaders to speak on
the latest findings that can affect how you practice.

www.peipconference.ca

BIG ANNOUNCEMENTS

THE NUTRITION PROPOSITION BOOK HAS JUST BEEN RELEASED

Check it out at nutritionproposition.com and think about picking up a copy on Amazon. All the evidence you ever wanted about nutrition and the only nutrition book that won’t tell you what to eat.

 

BS Medicine Podcast

BedMed: The High Blood Pressure Study

This pragmatic trial is now recruiting in BC. Make a difference and get involved with pragmatic trials (www.pragmatictrials.ca)

PEER Tools

Search

Recent Posts

Archives

Categories

Meta